APA (7th ed.) Citation

Mazagatos, C., Mendioroz, J., Rumayor, M., Gallardo García, V., Álvarez Río, V., Cebollada Gracia, A., . . . García Comas, L. (2024). Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain. Influenza & Other Respiratory Viruses, 18(5), 1. https://doi.org/10.1111/irv.13294

Chicago Style (17th ed.) Citation

Mazagatos, Clara, et al. "Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain." Influenza & Other Respiratory Viruses 18, no. 5 (2024): 1. https://doi.org/10.1111/irv.13294.

MLA (9th ed.) Citation

Mazagatos, Clara, et al. "Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain." Influenza & Other Respiratory Viruses, vol. 18, no. 5, 2024, p. 1, https://doi.org/10.1111/irv.13294.